TrademarkDir
F1LCDX
LIVE

Serial Number

90237610

Owner

Foundation Medicine, Inc.

Attorney

Douglas R. Wolf

Filing Date

Oct 6, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

F1LCDX Trademark

Serial Number: 90237610 • Registration: 7055879

F1LCDX is a trademark filed by Foundation Medicine, Inc. on October 6, 2020. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Foundation Medicine, Inc. (54 trademarks)

One Kendall Square, Suite B6501
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

October 6, 2020

Registration Date

May 16, 2023

Published for Opposition

April 13, 2021

Goods & Services

genomic and molecular medical testing for cancer and other diagnostic or treatment purposes; diagnostic services, namely, medical diagnostic testing for cancer and other diseases and disorders; providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical data and information to healthcare professionals

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 16, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 16, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 12, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2023 CNPR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 28, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Feb 28, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 28, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 28, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 29, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 29, 2022 GNFR
SU - FINAL REFUSAL - WRITTEN
Aug 29, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2022 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 24, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 24, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 24, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 23, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 20, 2021 AITU
USE AMENDMENT FILED
Dec 2, 2021 IUAF
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 2, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 2, 2021 COAR
TEAS STATEMENT OF USE RECEIVED
Nov 29, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2021 CNEA
ASSIGNED TO EXAMINER
Mar 2, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2020 NWOS
NEW APPLICATION ENTERED
Oct 9, 2020 NWAP

Related Trademarks

More from this Owner

FOUNDATIONMARKERS

FOUNDATIONMARKERS

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE PGX

FOUNDATIONONE PGX

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.